Osaic Holdings’s Dogwood Therapeutics DWTX Stock Holding History

Osaic Holdings’s Portfolio DWTX Stock Details DWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-1,617	Closed	-$14.9K	–	7602
2023 Q1	$14.9K	Buy	1,617 +504	+45%	+$4.01K	﹤0.01%	5748
2022 Q4	$7K	Buy	1,113 +768	+223%	+$5.79K	﹤0.01%	6150
2022 Q3	$3K	Buy	345 +273	+379%	+$38.5K	﹤0.01%	6686
2022 Q2	$8K	Buy	72 +5	+7%	+$523	﹤0.01%	6260
2022 Q1	$8K	Sell	67 -7	-9%	-$1.02K	﹤0.01%	6287
2021 Q4	$9K	Buy	74 +2	+3%	+$254	﹤0.01%	6358
2021 Q3	$10K	Buy	72 +9	+14%	+$1.25K	﹤0.01%	6213
2021 Q2	$10K	Sell	63 -81	-56%	-$11.5K	﹤0.01%	6084
2021 Q1	$21K	Buy	144 +127	+747%	+$22.1K	﹤0.01%	5447
2020 Q4	$3K	Buy	+17	New	+$4.1K	﹤0.01%	5994

Other funds holding DWTX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

MCG

McCollum Christoferson Group Amherst, New York $341M AUM 15.01% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

Osaic Holdings's DWTX Position: Q2 2023 in Review

Osaic Holdings sold out of Dogwood Therapeutics (DWTX) in Q2 2023, closing a stake of 1,617 shares — an estimated $14.9K sold.

Osaic Holdings first reported a position in DWTX in Q4 2020 and held it in 10 quarters. The position peaked at $21K in Q1 2021. 24 funds tracked by Wall St. Rank hold DWTX as of Q2 2023.

Osaic Holdings reported no remaining Dogwood Therapeutics position as of Q2 2023 after selling out during the quarter.
Osaic Holdings sold 1,617 Dogwood Therapeutics shares in Q2 2023, an estimated $14.9K.
Osaic Holdings first reported a position in Dogwood Therapeutics in Q4 2020 and held it in 10 quarters.
Osaic Holdings's Dogwood Therapeutics position peaked at $21K in Q1 2021.
24 funds tracked by Wall St. Rank held Dogwood Therapeutics as of Q2 2023.

Based on Osaic Holdings's 13F filing for Q2 2023, filed 10 Aug 2023.